COMPUTATIONAL DESIGN AND EVALUATION OF NOVEL ENZYME CATALYSTS
新型酶催化剂的计算设计和评估
基本信息
- 批准号:8364203
- 负责人:
- 金额:$ 0.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-hydroxybutanalActive SitesBiological ModelsBiomedical ResearchCatalytic DomainElasticityEnzymesEvaluationFundingGrantHigh Performance ComputingMethodsNational Center for Research ResourcesNatural regenerationPassive ImmunizationPenetrationPrincipal InvestigatorProceduresProcessProductionProteinsProtocols documentationQuantum MechanicsReactionReportingResearchResearch InfrastructureResourcesSolventsSourceStructureTimeUnited States National Institutes of HealthWatercatalystcomputing resourcescostdesigngene therapyhuman tissuemolecular dynamicsnext generationnovel
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
In 2008, a successful computational design procedure was reported that yielded active enzyme catalysts for the Kemp elimination and the retro-aldol reaction. We studied these proteins together with a set of previously unpublished inactive designs in order to determine the sources of activity or lack thereof, and to predict which of the designed structures are most likely to be catalytic. Methods that range from quantum mechanics (QM) on truncated model systems to the treatment of the full protein with ONIOM QM/MM and AMBER molecular dynamics (MD) were explored. The most effective procedure involved explicit-solvent, periodic-boundary molecular dynamics, and a general MD protocol was established (see supporting information "Evaluation and Ranking of Enzyme Designs with Molecular Dynamics"). Substantial deviations from the ideal catalytic geometries were observed for a number of designs. Penetration of water into the catalytic site and insufficient residue-packing around the active site are the main factors that can cause enzyme designs to be inactive. Where in the past, computational evaluations of designed enzymes were too time-extensive for practical consideration, it has now become feasible to rank candidates computationally prior to and in conjunction with experimentation, thus markedly increasing the efficiency of the enzyme design process. Employing computational resources from the DESRES Anton machine will be instrumental to further develop and refine our MD-assisted enzyme design protocol and to facilitate the production of next-generation catalysts for a plethora of useful applications that range from alternative fuels to regenerating human tissue elasticity to novel passive immunizations and gene therapy.
该子项目是利用资源的众多研究子项目之一
由 NIH/NCRR 资助的中心拨款提供。子项目的主要支持
并且子项目的主要研究者可能是由其他来源提供的,
包括其他 NIH 来源。 子项目可能列出的总成本
代表子项目使用的中心基础设施的估计数量,
NCRR 赠款不直接向子项目或子项目工作人员提供资金。
2008 年,据报道,一种成功的计算设计程序产生了用于 Kemp 消除和逆羟醛反应的活性酶催化剂。我们将这些蛋白质与一组先前未发表的非活性设计一起研究,以确定活性或缺乏活性的来源,并预测哪些设计的结构最有可能具有催化作用。探索了从截断模型系统上的量子力学 (QM) 到使用 ONIOM QM/MM 和 AMBER 分子动力学 (MD) 处理完整蛋白质的方法。最有效的程序涉及显式溶剂、周期边界分子动力学,并建立了通用MD方案(参见支持信息“分子动力学酶设计的评估和排名”)。在许多设计中观察到与理想催化几何形状的显着偏差。水渗透到催化位点和活性位点周围残留物填充不足是导致酶设计失活的主要因素。过去,设计酶的计算评估对于实际考虑而言过于耗时,现在可以在实验之前并结合实验对候选物进行计算排名,从而显着提高酶设计过程的效率。利用 DESRES Anton 机器的计算资源将有助于进一步开发和完善我们的 MD 辅助酶设计方案,并促进下一代催化剂的生产,这些催化剂适用于从替代燃料到再生人体组织弹性等众多有用的应用。新型被动免疫和基因治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENDALL N HOUK其他文献
KENDALL N HOUK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENDALL N HOUK', 18)}}的其他基金
Steroselectivity of Synthetically Valuable Enzyme Catalysts
有合成价值的酶催化剂的立体选择性
- 批准号:
9884779 - 财政年份:2018
- 资助金额:
$ 0.11万 - 项目类别:
Mapping the Evolution of a Novel Enzyme by Experiment and Computation
通过实验和计算绘制新型酶的进化图
- 批准号:
8625310 - 财政年份:2012
- 资助金额:
$ 0.11万 - 项目类别:
Mapping the Evolution of a Novel Enzyme by Experiment and Computation
通过实验和计算绘制新型酶的进化图
- 批准号:
8448124 - 财政年份:2012
- 资助金额:
$ 0.11万 - 项目类别:
Mapping the Evolution of a Novel Enzyme by Experiment and Computation
通过实验和计算绘制新型酶的进化图
- 批准号:
8298035 - 财政年份:2012
- 资助金额:
$ 0.11万 - 项目类别:
LARGE-SCALE COMPUTATIONS OF CHEMICAL AND BIOLOGICAL REACTION RATES AND MECHANIS
化学和生物反应速率和机制的大规模计算
- 批准号:
8171769 - 财政年份:2010
- 资助金额:
$ 0.11万 - 项目类别:
LARGE-SCALE COMPUTATIONS OF CHEMICAL AND BIOLOGICAL REACTION RATES AND MECHANIS
化学和生物反应速率和机制的大规模计算
- 批准号:
7956108 - 财政年份:2009
- 资助金额:
$ 0.11万 - 项目类别:
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
The role of PRMT5 in preventing intra-chromosomal deletions in cancer cells
PRMT5 在预防癌细胞染色体内缺失中的作用
- 批准号:
10728560 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别:
Chemical tools to investigate chain-flipping in quorum signal synthases
研究群体信号合酶链翻转的化学工具
- 批准号:
10645548 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别:
Mechanism of Energy Transduction and Substrate Activation in Biological Nitrogen Fixation
生物固氮中的能量转换和底物激活机制
- 批准号:
10566582 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10599654 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别: